A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs by D. G. Cunningham Owens – Clinical Insights into Dru

Introduction

In the evolving landscape of psychiatric medicine, few topics demand as much clinical nuance as the neurological side-effects of antipsychotic medications. A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs, authored by D. G. Cunningham Owens and published by Cambridge University Press, stands as an indispensable resource for Indian psychiatrists, neurologists, pharmacology students, and mental health professionals. This hardbound volume dispels the common myth that extrapyramidal symptoms (EPS) are a relic of older treatments, offering a comprehensive, evidence-based examination of these complex drug-induced disorders.

Book Overview

This meticulously updated second edition redefines the clinical boundaries of acute dystonias, drug-induced parkinsonism, akathisia, and tardive dyskinesia. Owens presents demographic and epidemiological data specific to diverse populations, including insights relevant to Indian clinical settings where antipsychotic prescribing patterns vary widely. The book emphasizes how prescribing choices—dose, duration, polypharmacy, and drug selection—powerfully influence the development and severity of EPS. With a light, engaging narrative style and abundant real-world case examples, this volume bridges the gap between theoretical pharmacology and bedside practice.

Key Highlights

• Thoroughly revised and rewritten with recent data and expanded references from global and Indian studies
• New chapter on 'atypical' antipsychotics, critically examining the concept of atypicality and its clinical relevance
• Over 400 pages of detailed content, liberally illustrated with clinical vignettes and tables
• Discussion of ongoing controversies, including subjective drug effects and the relationship between akathisia and restless legs syndrome
• Practical guidance for managing and preventing EPS in everyday psychiatric practice

Inside the Book

The book opens with a historical perspective on antipsychotic-induced movement disorders, then systematically progresses through each major EPS subtype. Chapters cover pathophysiology, risk factors, diagnostic criteria, and management strategies. A dedicated section explores the subjective experience of drug effects—often overlooked in standard texts—and how patient-reported outcomes can guide therapy. The final chapters delve into the neurobiological underpinnings of tardive syndromes and the role of novel antipsychotics in minimizing motor complications. Appendices include quick-reference tables for clinicians.

Key Topics

• Acute dystonic reactions and their management in emergency settings
• Drug-induced parkinsonism: differentiation from idiopathic Parkinson's disease
• Akathisia: clinical presentation, measurement scales, and treatment algorithms
• Tardive dyskinesia: epidemiology, risk stratification, and evidence-based interventions
• The atypical antipsychotic debate: efficacy versus side-effect profiles
• Restless legs syndrome vs. akathisia: diagnostic challenges
• Subjective tolerability and adherence in long-term antipsychotic therapy

Reader Benefits

Indian readers will find the book especially valuable for its emphasis on real-world prescribing patterns and cultural considerations. The case studies include scenarios from both urban and rural settings, addressing issues like limited access to second-generation antipsychotics and the high prevalence of polypharmacy. The clear, jargon-free writing makes complex neuropharmacology accessible to postgraduate students and practicing clinicians alike. Each chapter ends with a summary of key takeaways, enabling quick revision before exams or clinical rounds.

Learning Outcomes

By the end of this book, readers will be able to identify early signs of EPS in patients on antipsychotics, differentiate between various movement disorders, select appropriate medications to minimize side-effects, and counsel patients and families about treatment risks. The book also equips clinicians to critically evaluate claims about 'atypical' antipsychotics and make informed prescribing decisions based on individual patient profiles.

Who Should Read

• Psychiatrists and psychiatric residents in India
• Neurologists managing drug-induced movement disorders
• Clinical pharmacologists and pharmacy students
• Mental health nurses and psychiatric social workers
• Medical students preparing for speciality exams (NEET PG, AIIMS, etc.)
• Researchers in psychopharmacology and neurotherapeutics

About the Author

D. G. Cunningham Owens is a renowned British psychiatrist and clinical academic with decades of experience in psychopharmacology and movement disorders. A former professor at the University of Edinburgh and consultant psychiatrist at the Royal Edinburgh Hospital, Owens has published extensively on antipsychotic side-effects and is considered a global authority on extrapyramidal syndromes. His writing combines rigorous science with a humane understanding of patient experience.

About the Publisher

Cambridge University Press is one of the world's oldest and most prestigious academic publishers, known for its high-quality textbooks and reference works in medicine, science, and humanities. With a strong commitment to evidence-based knowledge, Cambridge titles are trusted by universities and hospitals across India for their accuracy, depth, and clinical utility.

Conclusion

A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs is more than a textbook—it is a clinical companion for anyone who prescribes or monitors antipsychotic therapy. In an era where newer drugs are often assumed to be free of motor complications, this book provides the critical perspective needed to practice safe, effective psychiatry. For Indian students and professionals seeking a definitive, up-to-date reference on this challenging topic, Cunningham Owens' work is an essential addition to your library.